S.Korea signs with Pfizer for extra 40 mln COVID-19 vaccine doses
- Country:
- Korea Rep
South Korea said on Saturday it signed a contract with Pfizer Inc to purchase an additional 40 million doses of its COVID-19 vaccine amid fears of spiking infections at home.
That brings the current amount of Pfizer vaccines to 66 million doses, it said in a statement.
It added that it had secured a total of 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's, and Novavax.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- AstraZeneca PLC
- Pfizer
- Moderna Inc
- Pfizer Inc
- Novavax
- Johnson & Johnson's
- South Korea
Advertisement
ALSO READ
Pfizer RSV shot meets goals in trial of high-risk adults under age 60
Health News Roundup: Pfizer RSV shot meets goals in trial of high-risk adults under age 60; Novartis to cut 680 jobs in product development and more
Health News Roundup: Pfizer RSV shot meets goals in trial of high-risk adults under age 60; Cuba says drug use on the rise, especially among youth and more
Pfizer vs Moderna battle over COVID vaccine patents begins in UK